Dr. Joshua Degani Named CEO of IOPtima
Dr. Joshua Degani Named CEO of IOPtima
November 20, 2006
Press Release
Dr. Joshua Degani has been appointed to the position of CEO of IOPtima, a portfolio company of the Bio-Light Group.
IOPtima is developing a laser device for use in surgery to treat glaucoma.
Dr. Degani has been working in the development and management of lasers since 1976. He previously served as Chief Operating Office and VP R&D for Curelight, which develops, manufactures and markets phototherapy products. Previously, he served as Vice President for Research and Development for Laser Industries Ltd. which also specialized in the development, manufacture and marketing of laser medical devices and electroptic systems
Dr. Degani was brought into IOPtima as it increasingly became clear that the company had progressed to the point where there was a need for a seasoned executive with experienced in the development and management of laser medical equipment, to successfully lead the company into the future.
